A research team has succeeded in experimentally evolving the common bacteria under pressure from a large number of individual antibiotics, and identified the mechanisms and constraints underlying evolved drug resistance. Their findings help develop drug-treatment strategies that minimize the chance that bacteria will develop resistance.